<SEC-DOCUMENT>0001654954-18-000851-index.html : 20180130
<SEC-HEADER>0001654954-18-000851.hdr.sgml : 20180130
<ACCEPTANCE-DATETIME>20180130074918
ACCESSION NUMBER:		0001654954-18-000851
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180123
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180130
DATE AS OF CHANGE:		20180130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medite Cancer Diagnostics, Inc.
		CENTRAL INDEX KEY:			0000075439
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				364296006
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-00935
		FILM NUMBER:		18557485

	BUSINESS ADDRESS:	
		STREET 1:		414 NORTH ORLEANS STREET
		STREET 2:		SUITE 502
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60610
		BUSINESS PHONE:		4078490290

	MAIL ADDRESS:	
		STREET 1:		414 NORTH ORLEANS STREET
		STREET 2:		SUITE 502
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60610

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CytoCore Inc
		DATE OF NAME CHANGE:	20060815

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOLECULAR DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20011009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMPERSAND MEDICAL CORP
		DATE OF NAME CHANGE:	19990527
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mdit8k_jan232018.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: mdit8k_jan232018.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>LETTER
<TEXT>
Document 2 - file: ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>